摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(+)-14,15-didehydroquebrachamine | 785043-41-6

中文名称
——
中文别名
——
英文名称
(+)-14,15-didehydroquebrachamine
英文别名
(15R)-15-ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaene
(+)-14,15-didehydroquebrachamine化学式
CAS
785043-41-6
化学式
C19H24N2
mdl
——
分子量
280.413
InChiKey
ZQPHBDYQXPPKQF-IBGZPJMESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.2
  • 重原子数:
    21
  • 可旋转键数:
    1
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.47
  • 拓扑面积:
    19
  • 氢给体数:
    1
  • 氢受体数:
    1

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (+)-14,15-didehydroquebrachamine叔丁基过氧化氢二叔丁基过氧化物三氟乙酸 作用下, 以 四氢呋喃 为溶剂, 以82%的产率得到(+)-(14S,15R)-epoxy-quebrachamine
    参考文献:
    名称:
    长春花生物碱及相关化合物的合成。100.具有曲霉精和quebrachamine环系统的化合物的立体选择性氧化反应。首先合成一些含有环氧环的生物碱。
    摘要:
    首次合成生物碱(-)-甲胺(3),(+)-茶碱/香豆碱(4),(+)-N(a)-甲基茶碱/ he碱(5)和(-)-lochnericine(2 )是通过立体选择性环氧化反应从(-)-烟粉碱(1)开始,通过具有蛇精精和quebrachamine骨架的中间体实现的。
    DOI:
    10.1021/jo020386r
点击查看最新优质反应信息

文献信息

  • Synthesis of vinca alakaloids and realated compounds<b>98</b>. Oxidation with dimethyldioxirane of compounds containing the aspidospermane and quebrachamine ring system. A simple synthesis of (7<i>S</i>,20<i>S</i>)-(+)-rhazidigenine and (2<i>R</i>,7<i>S</i>,20<i>S</i>)-(+)-rhazidine
    作者:János Éles、György Kalaus、Lajos SzabÓ、Albert LÉvai、IstvÁn Greiner、MÁria KajtÁr-Peredy、PÁl SzabÓ、Csaba SzÁntay
    DOI:10.1002/jhet.5570390423
    日期:2002.7
    The oxidation of (-)-tabersonine (1) with dimethyldioxirane (DMD) in neutral and acidic medium gave 16-hydroxytabersonine-N-oxide (3) and the didehydrovincamine isomers 4 and 5, respectively. (+)-14,15-Didehydro-quebrachamine (7) furnished the hydroxyindolenine 9, and the pentacyclic derivative 11. (+)-Quebrachamine (8) and DMD in neutral medium gave (7S,20S)-(+)-rhazidigenine (12) which was converted
    在中性和酸性介质中,用二甲基二环氧乙烷(DMD)氧化(-)-大黄碱(1)分别得到16-羟基大黄碱-N-氧化物(3)和二脱氢长春胺异构体4和5。(+)-14,15-Didehydro-quebrachamine(7)提供了羟基吲哚啉9和五环衍生物11。(+)-瓜拉巴胺(8)和DMD在中性介质中得到(7 S,20 S)-(+)-rhazidigenine(12),将其转化为(2 R,7 S,20 S)-(+)-rhazidine (13b)用盐酸。
  • Synthesis of Vinca Alkaloids and Related Compounds. 100. Stereoselective Oxidation Reactions of Compounds with the Aspidospermane and Quebrachamine Ring System. First Synthesis of Some Alkaloids Containing the Epoxy Ring<sup>1</sup><sup>a</sup>
    作者:János Éles、György Kalaus、István Greiner、Mária Kajtár-Peredy、Pál Szabó、György Miklós Keserû、Lajos Szabó、Csaba Szántay
    DOI:10.1021/jo020386r
    日期:2002.10.1
    The first syntheses of the alkaloids (-)-mehranine (3), (+)-voaphylline/conoflorine (4), (+)-N(a)-methylvoaphylline/hecubine (5), and (-)-lochnericine (2) were achieved by stereoselective epoxidation starting from (-)-tabersonine (1), through intermediates with the aspidospermane and quebrachamine skeleton.
    首次合成生物碱(-)-甲胺(3),(+)-茶碱/香豆碱(4),(+)-N(a)-甲基茶碱/ he碱(5)和(-)-lochnericine(2 )是通过立体选择性环氧化反应从(-)-烟粉碱(1)开始,通过具有蛇精精和quebrachamine骨架的中间体实现的。
查看更多

同类化合物

(1aR,13S,13aS)-13-乙基-1a,4,5,10,11,12,13,13a-八氢-2H-3,13-甲桥环氧乙烷并[9,10]氮杂环十一碳五烯并[5,4-b]吲哚 (-)-dehydroquebrachamine (-)-N-methylquebrachamine tetradehydro-(+)-quebrachamine (+)-14,15-didehydroquebrachamine quebrachamine 5,6,11,12-tetrahydro-4H,13aH-3a,13-propanofuro[3',2':8,9]azonino[5,4-b]indol-2(3H)-one oxoquebrachamine (+)-N-methylquebrachamine (+/-)-vincadine Vincaminoreine vincadine quebrachamine (+/-)-epivincadine 14,15,16,17-Dehydroquebrachamin (15S)-15-ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,13,16-hexaene (15R)-15-ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,13,16-hexaene 15-Ethyl-11-aza-1-azoniapentacyclo[13.3.1.01,13.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaene 15-ethyl-11-aza-1-azoniapentacyclo[13.3.1.01,13.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaene;magnesium(1+) monohydride;hydroxide 5,10-Dioxo-quebrachamin 15-Ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,13,16-hexaene methyl N-[(15-ethyl-2-oxo-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-ylidene)amino]carbamate 15-Ethyl-11,18-dimethyl-17-oxa-1,11-diazapentacyclo[13.4.1.04,12.05,10.016,18]icosa-4(12),5,7,9-tetraene 15-Ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene-16,17-diol 15-Ethyl-11-methyl-17-oxa-1,11-diazapentacyclo[13.4.1.04,12.05,10.016,18]icosa-4(12),5,7,9-tetraen-13-ol (1aR,13S,13aS)-13-Ethyl-1a,4,5,10,11,12,13,13a-octahydro-10-methyl-2H-3,13-methanooxireno[9,10]azacycloundecino[5,4-b]indole 15-Ethyl-17-oxa-1,11-diazapentacyclo[13.4.1.04,12.05,10.016,18]icosa-4(12),5,7,9-tetraen-13-ol 15-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4,6,8-tetraen-19-ol 15-Ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-17-ol 17-Ethoxy-19-oxa-5,15-diazapentacyclo[13.6.1.01,18.04,12.06,11]docosa-4(12),6,8,10-tetraene Ervayunine 15-Ethyl-11-methyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene-16,17-diol 15-Ethyl-17-oxa-1,11-diazapentacyclo[13.4.1.04,12.05,10.016,18]icosa-4(12),5,7,9-tetraen-2-ol 15-Ethyl-17-oxa-1,11-diazapentacyclo[13.4.1.04,12.05,10.016,18]icosa-4(12),5,7,9-tetraen-19-one Vincadin 15-Ethyl-13-hydroxy-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-19-one (±)-N-methylquebrachamine quebrachamine Methyl 17-ethyl-19-oxa-3,13-diazapentacyclo[15.2.1.02,10.04,9.013,18]icosa-2(10),4,6,8,15-pentaene-1-carboxylate 15-Ethyl-11-(methoxymethyl)-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene 9-Methoxy-quebrachamin dl-Vincaminorein Methyl 15-ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaene-13-carboxylate Methyl 15-ethyl-8-methoxy-11-methyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5(10),6,8-tetraene-13-carboxylate 13-Ethyl-9-methoxy-1a,4,5,10,11,12,13,13a-octahydro-2h-3,13-methanooxireno[9,10]azacycloundecino[5,4-b]indole 15-Ethyl-8-hydroxy-17-oxa-1,11-diazapentacyclo[13.4.1.04,12.05,10.016,18]icosa-4(12),5(10),6,8-tetraen-2-one